U.S., Japan and China Advance Stem Cell Commercialization While Korea Works to Close Gaps
A researcher at Cha Biotech is observing stem cells at a Good Manufacturing Practice (GMP)-certified facility / Provided by CHA Biotech
Ra Jeong-chan, Chairman of NatureCell, is announcing plans to build a production facility (BioStar Stem Cell Campus) in Baltimore for JointStem, a stem cell injection treatment for knee osteoarthritis, at The Line DC hotel in Washington, D.C., on November 20, last year 2025.11.20 / News1
Schematic diagram of stem cell-mimicking near-infrared (NIR)-responsive microneedles for the treatment of chronic diabetic wounds / Provided by the National Research Foundation of Korea
